{"slideshow_credits": null, "snippet": "To the Brits, Pfizer&#8217;s $101 billion bid for AstraZeneca is about sciences, not taxes.", "abstract": "Joe Nocera Op-Ed column notes that Pfizer's proposed takeover of British company AstraZeneca has alarmed many British observers who fear cuts to AstraZeneca's multibillion-dollar annual research budget will diminish country's scientific standing; holds while acquisition and cutbacks have come to dominate the pharmaceutical industry, innovation has continued apace at small companies that are eventually bought out by their larger counterparts.", "section_name": "Opinion", "print_page": "21", "document_type": "article", "byline": {"person": [{"firstname": "Joe", "role": "reported", "lastname": "NOCERA", "rank": 1, "organization": ""}], "original": "By JOE NOCERA", "contributor": ""}, "web_url": "http://www.nytimes.com/2014/05/13/opinion/nocera-science-vs-taxes.html", "lead_paragraph": "To the Brits, Pfizer&#8217;s $101 billion bid for AstraZeneca is about sciences, not taxes.", "headline": {"main": "Science vs. Taxes", "print_headline": "Science vs. Taxes", "content_kicker": "Op-Ed Columnist", "kicker": "Op-Ed Columnist"}, "_id": "53716f3b38f0d812d61f25ab", "word_count": "811", "multimedia": [{"height": 75, "url": "images/2012/01/27/opinion/Nocera_New/Nocera_New-thumbStandard-v2.jpg", "legacy": {"thumbnail": "images/2012/01/27/opinion/Nocera_New/Nocera_New-thumbStandard-v2.jpg", "thumbnailwidth": "75", "thumbnailheight": "75"}, "subtype": "thumbnail", "width": 75, "type": "image"}], "pub_date": "2014-05-13T00:00:00Z", "source": "The New York Times", "news_desk": "Editorial", "keywords": [{"value": "Pfizer Inc", "name": "organizations", "is_major": "Y", "rank": "1"}, {"value": "AstraZeneca PLC", "name": "organizations", "is_major": "Y", "rank": "2"}, {"value": "Drugs (Pharmaceuticals)", "name": "subject", "is_major": "Y", "rank": "3"}, {"value": "Research", "name": "subject", "is_major": "N", "rank": "4"}, {"value": "Mergers, Acquisitions and Divestitures", "name": "subject", "is_major": "N", "rank": "5"}, {"value": "Corporate Taxes", "name": "subject", "is_major": "N", "rank": "6"}, {"value": "Great Britain", "name": "glocations", "is_major": "Y", "rank": "7"}, {"value": "United States", "name": "glocations", "is_major": "N", "rank": "8"}], "blog": [], "subsection_name": null, "type_of_material": "Op-Ed"}